New immnotherapy can shrink otherwise untreatable breast, lung and mesothelioma tumors

Researchers at Memorial Sloan Kettering have deveoped the world's first immunotherapy that can shrink treatment-resistant lung, breast and mesothelioma tumors in some two million patients.

from Health News | Mail Online https://ift.tt/2uyBT1c